Skip to main content

BioAtla Inc

For the period ended Dec 31, 2023. Filed Mar 26, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 26, 2024

BCAB$1.74-44.7%Stored close · as of Aug 28, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Statements of cash flows

(in thousands)

Years ended December 31,
20232022
Cash flows from operating activities
Net loss$(123,462)$(106,482)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization1,2211,199
Loss on disposal of property and equipment213
Stock-based compensation13,54414,563
Changes in operating assets and liabilities:
Prepaid expenses and other assets(11)(2,611)
Accounts payable and accrued expenses5,2843,411
Right-of-use assets and lease liabilities, net(593)(513)
Net cash used in operating activities(104,015)(90,420)
Cash flows from investing activities
Purchases of property and equipment(98)(268)
Proceeds from sale of property and equipment—3
Net cash used in investing activities(98)(265)
Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance costs—61,682
Proceeds from issuance of common stock under Employee Stock Purchase Plan336289
Payments for taxes related to net settlement of equity awards(259)(758)
Net cash provided by financing activities7761,213
Net decrease in cash and cash equivalents(104,036)(29,472)
Cash and cash equivalents, beginning of period215,507244,979
Cash and cash equivalents, end of period$111,471$215,507
Supplemental disclosure of non-cash investing and financing activities
Property and equipment additions included in accounts payable and accrued expenses$—$1
Tax related to net settlement of equity awards included in accounts payable and accrued expenses$6$67
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.